Now in its 31st edition, MTI is Europe’s longest running healthcare investment and partnering forum, bringing together a fantastic range of breakthrough healthcare and life science firms seeking investment and partnerships with some of the most pro-active and ambitious investors in the sector.
Since 2003 we have been at the centre of the rapidly evolving healthcare technology venture ecosystem and specialised in bringing together over 1000 venture-stage companies with investors including family offices, private wealth holders, VC’s, private equity, healthcare corporations, angel investors and many more.
Each event sees up to 40 technology companies pitching investment opportunities to an audience of 150 delegates. Central to the event is a conference programme that will address some of the major challenges and opportunities in the healthcare investment sector today.
To learn more about participation and to stay up to date with the latest announcements. Please contact Liam Smith firstname.lastname@example.org to find out more.
This unrivalled platform will:
The MTI events deliver the best ratio of investors to presenting companies, giving all attendees the maximum opportunity to meet, network and learn from the best in the business ensuring you connect with the right investors and the right investment opportunities.
Do not miss this unique opportunity to meet with some of the most proactive entrepreneurs and investors in healthcare and life sciences, learn how to fine-tune your strategy and ultimately maximise the potential for return from the sector.
The MTI conference programmes address the biggest topics in the industry today, from investment topics such as “Where is the money coming from?” and “What do family offices look for and how do they invest?” to wider challenges such as “How does healthcare economics playout in the real world?” and “How do you plan and execute a successful exit”.
The conference programmes are developed in conjunction with the MTI Investor Advisory Board – a collection of the biggest investors in the sector with assets under management of over €40bn.
Our speaking faculties represent the truly global nature of the healthcare and life science industry with panellists drawn from leading organisations from Europe, North America, the Middle East and Asia.
Brochure coming soon
The core of our speaker faculty is made-up of some of the industry’s most active and ambitious investors joining on-stage discussion to give the latest insight into their investment strategy, the evolution of the sector, the most promising future opportunities and ultimately the opportunities they are looking for and make investments in.
Leading the forum programme we are honoured to welcome back as chairman Dr Benoît Dubuis the Executive Director of Campus Biotech and the President of the world-renowned Inartis Foundation.
Benoît has over 30 years of international experience in Life Sciences, both in industry and in the academic world. After his engineering training, his doctorate from ETH Zurich (ETH Medal 1995) and an academic activity in Cambridge and Cranfield in England, he held various management positions in pharmaceutical companies (Chemap, Ciba-Geigy / Novartis, Lonza), before joining the École Polytechnique Fédérale de Lausanne (EPFL) where he founded the Faculty of Life Sciences.
Confirmed speakers will be updated at regular intervals as the events draws closer. If you are interested in speaking at the event please contact the event manager:
+44(0)203 941 8019
Over the last 30 events we have showcased over 1000 venture-stage healthcare and life science companies to our unrivalled audience of investors. Representing all areas of healthcare and life sciences our presenting companies originate from over 37 countries and are at a range of different stages from pre-clinical to commercialisation.
For more information on how you can participate please email MouniraRuma@campdenwealth.com.
Having showcased over 1000 companies over the last 30 events, we have covered some of the most diverse areas of the healthcare sector. With our venture-stage companies looking typically for funding between €500,000 to €15m, they will cover a range of development stages including:
Ongoing Clinical Trials
The MTI Presenting Companies are revolutionising areas of life sciences including:
A selection of the previously confirmed presenting companies at MTI events include:
No other platform brings together such a comprehensive range of investment opportunities, all in one place, allowing investors of all types to discover first-hand those that will fit with their portfolio and be their next success story.
Why attend as a delegate?
· Be the first to uncover the latest investment opportunities from our unrivalled range of Presenting Companies
· Meet over 40 investment opportunities over the duration of 2 days
· Network with leading investors and healthcare corporations
· Learn how to adapt your investment strategy for today’s climate
· Take away the tools to help your portfolio companies develop and grow to their full potential
Who are the delegates?
Every year MTI brings together over 150 attendees who are working at the cutting-edge of healthcare and life science investment and partnering. Our investors represent some of the most pro-active and ambitious individuals including family offices, private wealth holders, VC’s, private equity, healthcare corporations, angel investors and many more.
In order to ensure the best possible mix of investors and venture-stage companies, admission to all MTI events is strictly controlled and open to all qualifying companies and individuals. The organisers reserve the right to restrict admittance and delegate places.
To see examples of the range of investors and specialists MTI attracts here are just some of our previous members of the Investor Advisory Board:
|Partner, Siemens Venture Capital, USA|
|General Partner, BioMed Partners, Switzerland|
|General Partner, VI Partners, Switzerland|
|Senior Managing Director, OrbiMed Healthcare Fund Management, Israel|
|Partner, Gilde Healthcare Partners, Netherlands|
|Managing Partner, Peppermint Venture Partners GmbH, Germany|
|Partner, Omega Fund Management, UK|
|Co-Head Venture Capital, Life Sciences Partner, Omnes Capital, France|
|Founding Partner, HealthCap Venture Capital, Sweden|
|President, Shafner Law Office, USA|
How to register
Special packages and early booking pricing are now available, see the Registration Page for more information or contact:
+44 (0)203 941 8018
Following on from MTI’s first ever virtual event in 2020 we are building on that success and hosting a fully integrated in-person and virtual event this year.
Taking place 13-14 October 2021 the virtual event will bring together a truly global audience of investors including family offices, private wealth holders, VC’s, private equity, healthcare corporations, angel investors with up to 28 technology companies pitching investment opportunities.
For more information click here….
Campden Wealth, 6th floor, 11 Bressenden Place, London, SW1E 5BY, United Kingdom